Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients

This nationwide, population-based study aimed to clarify the effects of immunosuppressive regimens on new-onset diabetes after liver transplantation (NODALT). The National Health Insurance database of Taiwan was explored for patients who received liver transplantation without pre-transplant diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fu-Chao, Lin, Huan-Tang, Lin, Jr-Rung, Yu, Huang-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571855/
https://www.ncbi.nlm.nih.gov/pubmed/28860788
http://dx.doi.org/10.2147/TCRM.S142348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571855/
https://www.ncbi.nlm.nih.gov/pubmed/28860788
http://dx.doi.org/10.2147/TCRM.S142348

Ejemplares similares